[1]
“Prognostic value of plasma EBV DNA for nasopharyngeal cancer patients during treatment with intensity-modulated radiation therapy and concurrent chemotherapy”, Radiol Oncol, vol. 52, no. 2, May 2018, Accessed: Sep. 24, 2026. Available: https://www.radioloncol.com/index.php/ro/article/view/2974